Literature DB >> 17846553

Background noise: the experience of chemotherapy-induced peripheral neuropathy.

Marie A Bakitas1.   

Abstract

BACKGROUND: A substantial portion of the 1.3 million persons diagnosed annually with cancer receive neurotoxic chemotherapy that may produce distressful symptoms and changes in functional ability. However, little is known about the symptom experience and daily life effects of chemotherapy-induced peripheral neuropathy (CIPN).
OBJECTIVE: To describe the CIPN symptom experience and the influence of symptoms on everyday life.
METHODS: This was a qualitative, exploratory, interpretive, descriptive study with semistructured interviews. A purposive sample of 28 participants was recruited from a rural National Cancer Institute-designated comprehensive cancer center. Interviews were audiotaped, transcribed verbatim, and imported into Atlas.ti software. Content analysis and constant comparative method were used to analyze the data.
RESULTS: Participants represented diversity in age (46-81 years), cancer type, time since diagnosis (3-198 months), neuropathy severity, and neurotoxic chemotherapy agents received. Content analysis yielded a rich, thick description of CIPN symptoms and the influence of the symptoms on functional ability and everyday life. Further interpretive analysis provided a description of the symptom experience through an overarching metaphor, Background Noise, and four major themes: (a) Becoming Aware; (b) Learning New Lyrics; (c) Functional, Emotional, and Social Role Cacophony; and (d) Learning to Live With It. Participants described significant physical limitations, emotional distress, and social role impairments due to CIPN.
CONCLUSIONS: Having CIPN results in diverse symptom patterns and degrees of physical symptom distress from mild to severe, emotional distress, alterations in functional ability, and social role impairment. Comprehensive clinical and research measures are needed to assess the full spectrum of CIPN effects on everyday life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846553     DOI: 10.1097/01.NNR.0000289503.22414.79

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  63 in total

Review 1.  The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Cindy S Tofthagen; Andrea L Cheville; Charles L Loprinzi
Journal:  Curr Oncol Rep       Date:  2020-04-22       Impact factor: 5.075

2.  Disparities and reverse disparities in HPV vaccination: A systematic review and meta-analysis.

Authors:  Jennifer C Spencer; William A Calo; Noel T Brewer
Journal:  Prev Med       Date:  2019-03-29       Impact factor: 4.018

3.  Impact of oxaliplatin-induced neuropathy: a patient perspective.

Authors:  Barbara K Bennett; Susanna B Park; Cindy S-Y Lin; Michael L Friedlander; Matthew C Kiernan; David Goldstein
Journal:  Support Care Cancer       Date:  2012-03-17       Impact factor: 3.603

4.  Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.

Authors:  Ellen M Lavoie Smith; Debra L Barton; Rui Qin; Preston D Steen; Neil K Aaronson; Charles L Loprinzi
Journal:  Qual Life Res       Date:  2013-03-30       Impact factor: 4.147

5.  The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.

Authors:  Natalie B Simon; Michael A Danso; Thomas A Alberico; Ethan Basch; Antonia V Bennett
Journal:  Qual Life Res       Date:  2017-06-29       Impact factor: 4.147

6.  A Hyperresponsive HPA Axis May Confer Resilience Against Persistent Paclitaxel-Induced Mechanical Hypersensitivity.

Authors:  Sharon L Kozachik; Gayle G Page
Journal:  Biol Res Nurs       Date:  2015-10-27       Impact factor: 2.522

7.  The Experience of Chemotherapy-Induced Peripheral Neuropathy Among Childhood Cancer Survivors.

Authors:  Caroline Mohrmann
Journal:  J Pediatr Oncol Nurs       Date:  2019-05-05       Impact factor: 1.636

Review 8.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

9.  Evaluation of the Semmes-Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy.

Authors:  Delma Aurélia da Silva Simão; Antônio Lúcio Teixeira; Raissa Silva Souza; Elenice Dias Ribeiro de Paula Lima
Journal:  Support Care Cancer       Date:  2014-05-09       Impact factor: 3.603

10.  Chemotherapy-induced peripheral neuropathy: an algorithm to guide nursing management.

Authors:  Cindy Tofthagen; Constance M Visovsky; Rachelle Hopgood
Journal:  Clin J Oncol Nurs       Date:  2013-04       Impact factor: 1.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.